Kasabach-Merritt Phenomenon

Phenomenon Kasabach–Merritt syndrome
DOI: 10.1097/mph.0b013e318281558e Publication Date: 2013-02-06T15:16:45Z
ABSTRACT
Kasabach-Merritt phenomenon (KMP) is a rare condition and optimal treatments have not yet been established, especially for cases that are unresponsive to first-line therapy. We retrospectively reviewed 11 KMP treated over the past 13 years in our institute.With exception of 1 case, steroids were administered as Eight required second-line or third-line The effective salvage therapies include interferon (n=1), radiotherapy chemotherapy (n=5). One case continues depend upon chemotherapy. Three refractory therapy dependent year age, whereas 8 effectively by 6 months age.Chemotherapy seems be most steroid-resistant cases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (4)
CITATIONS (23)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....